182 related articles for article (PubMed ID: 16484357)
1. Matrix metalloproteinase-2 activity, protein, mRNA, and tissue inhibitors in small arteries from pregnant and relaxin-treated nonpregnant rats.
Jeyabalan A; Kerchner LJ; Fisher MC; McGuane JT; Doty KD; Conrad KP
J Appl Physiol (1985); 2006 Jun; 100(6):1955-63. PubMed ID: 16484357
[TBL] [Abstract][Full Text] [Related]
2. Essential role for vascular gelatinase activity in relaxin-induced renal vasodilation, hyperfiltration, and reduced myogenic reactivity of small arteries.
Jeyabalan A; Novak J; Danielson LA; Kerchner LJ; Opett SL; Conrad KP
Circ Res; 2003 Dec; 93(12):1249-57. PubMed ID: 14593002
[TBL] [Abstract][Full Text] [Related]
3. Vascular matrix metalloproteinase-9 mediates the inhibition of myogenic reactivity in small arteries isolated from rats after short-term administration of relaxin.
Jeyabalan A; Novak J; Doty KD; Matthews J; Fisher MC; Kerchner LJ; Conrad KP
Endocrinology; 2007 Jan; 148(1):189-97. PubMed ID: 17053025
[TBL] [Abstract][Full Text] [Related]
4. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
[TBL] [Abstract][Full Text] [Related]
5. Relaxin promotes matrix metalloproteinase-2 and decreases Wnt/beta-catenin expression in the neonatal porcine heart.
Ho TY; Dilts MA; Bartol FF; Bagnell CA
Ann N Y Acad Sci; 2009 Apr; 1160():287-8. PubMed ID: 19416205
[TBL] [Abstract][Full Text] [Related]
6. [Expression of trophoblast invasion related genes mRNA and protein in human placenta in preeclampsia].
Zhang H; Lin QD; Qiao C
Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):509-13. PubMed ID: 17083831
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide inhibition increases aortic wall matrix metalloproteinase-9 expression.
Eagleton MJ; Peterson DA; Sullivan VV; Roelofs KJ; Ford JA; Stanley JC; Upchurch GR
J Surg Res; 2002 May; 104(1):15-21. PubMed ID: 11971672
[TBL] [Abstract][Full Text] [Related]
8. Porphyromonas gingivalis affects host collagen degradation by affecting expression, activation, and inhibition of matrix metalloproteinases.
Zhou J; Windsor LJ
J Periodontal Res; 2006 Feb; 41(1):47-54. PubMed ID: 16409255
[TBL] [Abstract][Full Text] [Related]
9. Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue.
Kubota T; Itagaki M; Hoshino C; Nagata M; Morozumi T; Kobayashi T; Takagi R; Yoshie H
J Periodontol; 2008 Jan; 79(1):166-73. PubMed ID: 18166107
[TBL] [Abstract][Full Text] [Related]
10. Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats.
Martinez ML; Rizzi E; Castro MM; Fernandes K; Bendhack LM; Gerlach RF; Tanus-Santos JE
Eur J Pharmacol; 2008 Dec; 599(1-3):110-6. PubMed ID: 18930722
[TBL] [Abstract][Full Text] [Related]
11. Relaxin increases secretion of tissue inhibitor of matrix metalloproteinase-1 and -2 during uterine and cervical growth and remodeling in the pig.
Lenhart JA; Ryan PL; Ohleth KM; Palmer SS; Bagnell CA
Endocrinology; 2002 Jan; 143(1):91-8. PubMed ID: 11751597
[TBL] [Abstract][Full Text] [Related]
12. Characterization of matrix metalloproteinase-2 and matrix metalloproteinase-9 and their inhibitors in equine granulosa cells in vivo and in vitro.
Sessions DR; Vick MM; Fitzgerald BP
J Anim Sci; 2009 Dec; 87(12):3955-66. PubMed ID: 19684269
[TBL] [Abstract][Full Text] [Related]
13. Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency.
Saito S; Trovato MJ; You R; Lal BK; Fasehun F; Padberg FT; Hobson RW; DurĂ¡n WN; Pappas PJ
J Vasc Surg; 2001 Nov; 34(5):930-8. PubMed ID: 11700497
[TBL] [Abstract][Full Text] [Related]
14. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats.
Martinez ML; Castro MM; Rizzi E; Fernandes K; Demacq C; Bendhack LM; Gerlach RF; Tanus-Santos JE
Eur J Pharmacol; 2008 Sep; 591(1-3):224-30. PubMed ID: 18634778
[TBL] [Abstract][Full Text] [Related]
15. Expression and localization of matrix metalloproteinases (MT1-MMP, MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) during synepitheliochorial placentation of goats (Capra hircus).
Uekita T; Yamanouchi K; Sato H; Tojo H; Seiki M; Tachi C
Placenta; 2004 Nov; 25(10):810-9. PubMed ID: 15451196
[TBL] [Abstract][Full Text] [Related]
16. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
[TBL] [Abstract][Full Text] [Related]
17. Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling.
Berceli SA; Jiang Z; Klingman NV; Pfahnl CL; Abouhamze ZS; Frase CD; Schultz GS; Ozaki CK
J Vasc Surg; 2004 May; 39(5):1084-90. PubMed ID: 15111865
[TBL] [Abstract][Full Text] [Related]
18. Relaxin enhances in-vitro invasiveness of breast cancer cell lines by up-regulation of matrix metalloproteases.
Binder C; Hagemann T; Husen B; Schulz M; Einspanier A
Mol Hum Reprod; 2002 Sep; 8(9):789-96. PubMed ID: 12200455
[TBL] [Abstract][Full Text] [Related]
19. Involvement of matrix metalloproteinases 2 and 9, tissue inhibitor of metalloproteinases and apoptosis in tissue remodelling in the sheep placenta.
Riley SC; Webb CJ; Leask R; McCaig FM; Howe DC
J Reprod Fertil; 2000 Jan; 118(1):19-27. PubMed ID: 10793622
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of tissue inhibitor of metalloproteinases-3 in cultured astrocytes and neurons regulates the activation of matrix metalloproteinase-2.
Liu W; Furuichi T; Miyake M; Rosenberg GA; Liu KJ
J Neurosci Res; 2007 Mar; 85(4):829-36. PubMed ID: 17279554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]